FTSE higher despite low volume session

In mid-morning trading the FTSE 100 is 15 points higher, making some hay while European markets take the day off.

An aerial view of the City of London
Source: Bloomberg

We’ve been able to dust off the ‘all time highs’ moniker for the DAX and US indices recently, but the FTSE 100 version remains in the cupboard unused. We may, however finally be seeing the index making another run towards the recent high of 6894 and then on to 6900, as the London market looks to emulate its cousins in Germany and the US. Even with an easing European Central Bank and in-line US job numbers, the index still looks uncomfortable at these levels. Although the picture from last week is supportive, the week ahead is not quite so encouraging, with only retail sales from the US and Japan in the latter half of the week offering hope of positive catalysts. 

TSB’s IPO has been priced this morning, ahead of the impending flotation. The IG grey market has moved lower in response to the decision to price the offering at around 15% below book value, but this move has already met with approval from clients who are beginning to view the lower offer as a more compelling valuation and a prudent recognition that the recent flood of IPOs has muddied the waters somewhat. 

US markets must rely on Friday’s job number if they are to retain the upward move that was so clearly in evidence last week. The remarkable fact is that around a quarter of the S&P 500’s gains for the year so far were made in the past week. While this might be a damning repudiation of the ‘sell in May’ theory, for 2014 at least, the fact is that rallies need fresh news to sustain them, and aside from retail sales later this week that news is worryingly absent.

Denne informasjonen er utarbeidet av IG, forretningsnavnet til IG Markets Limited. I tillegg til disclaimeren nedenfor, inneholder ikke denne siden oversikt over kurser, eller tilbud om, eller oppfordring til, en transaksjon i noe finansielt instrument. IG påtar seg intet ansvar for handlinger basert på disse kommentarene og for eventuelle konsekvenser som et resultat av dette. Ingen garanti gis for nøyaktigheten eller fullstendigheten av denne informasjonen. Personer som handler ut i fra denne informasjonen gjør det på egen risiko. Forskning gitt her tar ikke hensyn til spesifikke investeringsmål, finansiell situasjon og behov som angår den enkelte person som mottar dette. Denne informasjonen er ikke utarbeidet i samsvar med regelverket for investeringsanalyser, så derfor er denne informasjonen ansett å være markedsføringsmateriale. Selv om vi ikke er hindret i å handle i forkant av våre anbefalinger, ønsker vi ikke å dra nytte av dem før de blir levert til våre kunder. Se fullstendig disclaimer og kvartalsvis oppsummering.